Cepheid (CPHD) Looks Good: Stock Adds 5.3% in Session - Tale of the Tape

Loading...
Loading...
Cepheid CPHD was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down nearly 6% since Apr 1, 2014.

The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cepheid currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked medical stocks include Cynosure, Inc. CYNO, Delcath Systems, Inc. DCTH and Syneron Medical Ltd. ELOS. All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


CEPHEID INC CPHD: Free Stock Analysis Report

CYNOSURE INC-A CYNO: Free Stock Analysis Report

DELCATH SYS INC DCTH: Free Stock Analysis Report

SYNERON MED LTD ELOS: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...